Aimei Health Technology Co., Ltd
AFJK
$11.15
$0.0150.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 2.84% | 101.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.84% | 101.00% | |||
| Operating Income | -2.84% | -101.00% | |||
| Income Before Tax | -58.41% | -40.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -58.41% | -40.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -58.41% | -40.27% | |||
| EBIT | -2.84% | -101.00% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -48.37% | -40.29% | |||
| Normalized Basic EPS | -48.70% | -40.19% | |||
| EPS Diluted | -48.37% | -40.29% | |||
| Normalized Diluted EPS | -48.70% | -40.19% | |||
| Average Basic Shares Outstanding | -19.31% | 0.00% | |||
| Average Diluted Shares Outstanding | -19.31% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||